Searched for
GLOBAL PHARMACEUTICAL MARKET
ET Business Excellence & Leadership Summit 2026: Celebrating visionaries redefining growth & leadershipThe ET Business Excellence & Leadership Summit 2026 brought together leaders to discuss brand development, innovation, and sustainability. ...- AI productivity gains reflecting in salaries would take another 12 months: Wipro’s Jasjit KangWipro’s Jasjit Kang says broad productivity improvements remain elusive as the company looks for stronger AI, problem-solving and learning ...
- Beyond the 7% headline: S&P maps the forces driving India’s next growth phaseIndia’s economy is set to grow 7% in FY27, according to S&P Global, which sees domestic demand, private investment, manufacturing, trade, e...
- India and Qatar accelerate talks on Bilateral Investment Treaty and Free Trade Agreement amidst USD 10 billion investmentIndia and Qatar have agreed to accelerate discussions on a Bilateral Investment Treaty and Free Trade Agreement. Finance Minister Nirmala S...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
- Airbus stages maiden flight of new A350F freighterAirbus has initiated the maiden flight of its A350F freighter, aiming at breaking Boeing's market dominance. The A350F is set for a series ...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Market veterans favour value plays over crowded, expensive themesMarket experts project cautious optimism for Indian equities as valuations become less demanding and earnings growth aligns. Large-cap stoc...
- India’s healthcare AI opportunity could become the next big investment storyThe digital rails are ready. India now needs patient capital and founders ambitious enough to build on them.
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Forced labour and import: Reading India’s latest foreign trade policy additionsWith this notification in place, India has tried to put a protective layer for the domestic industry from unfair foreign competition.
- NSE shares fall 2%, trade marginally above IPO price after debut. Why are Macquarie, other brokerages bullish?NSE shares fell by 1.6% to Rs 1,790 following its stock market debut on Thursday. Brokerages Macquarie and Emkay assigned positive ratings,...
- Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 croreSanofi Healthcare India acquired a significant 15.2 percent stake in Sanofi India through an open market transaction. The company purchased...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Ukraine values India's engagement in restoring Black Sea freedom of navigation: FM SybihaThe meeting, which took place on the sidelines of the 81st United Nations General Assembly, also highlighted the importance of the waterway...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Protein boom sparks deals, partnerships across F&B spaceConsumer demand for protein in everyday staples is driving new product launches and supply deals. Food and beverage makers and cafe chains ...
- Global Market: China, Hong Kong stocks rise as investors await Trump-Xi meetingChina and Hong Kong stocks rose on Monday led by technology, healthcare, and property shares. Investors parsed high-level talks between US ...
- ETMarkets Smart Talk | Higher US rates could accelerate capital flight from EMs, but India remains better insulated: Rajesh PalviyaRajesh Palviya, Head of Research at Axis Direct, believes another US rate hike could tighten global financial conditions, strengthen the do...
- NDude Labs invests in nutraceutical ingredients firm NutriventiaThe investment will help Nutriventia strengthen its research and development pipeline, expand its global commercial presence and scale its ...
Load More
